Alterations in Selected Blood Parameters Associated with Type 2 Diabetes Mellitus
Perubahan Parameter Darah Tertentu yang Berhubungan dengan Diabetes Melitus Tipe 2
Keywords:
Type 2 Diabetes, Blood Parameters, Cholesterol, Triglycerides, Glycemic ControlAbstract
Background: Non-insulin-dependent diabetes mellitus (NIDDM), also known as type 2 diabetes, is associated with various physiological and biochemical changes in the blood. Understanding these changes is important for better disease management and prevention of complications. Aims of the Study: This study aimed to investigate certain physiological and biochemical changes in blood parameters among patients with non-insulin-dependent diabetes mellitus (NIDDM) and compare the results with a healthy control group. Methodology: The study included a total of 50 participants (men and women) aged between 20 and 70 years. They were divided into two groups: 30 diabetic patients (18 females and 12 males) and 20 healthy individuals (11 males and 9 females). Blood samples were analyzed to assess various hematological and biochemical parameters. Results: The findings revealed no significant differences in red blood cell count, total leukocyte count, and the percentages of neutrophils, lymphocytes, and eosinophils between the diabetic and control groups. However, a slight, non-significant increase in platelet count was noted in diabetic patients. A significant increase (p < 0.001) was observed in both total cholesterol and triglyceride levels in the diabetic group compared to the controls. Additionally, a statistically significant difference in age was found between diabetic patients and healthy individuals (p = 0.0007), suggesting age as a potential contributing factor in the development and progression of NIDDM. Conclusions: The study highlights the significant elevation of cholesterol and triglyceride levels in individuals with NIDDM and underscores the potential role of age in the onset and progression of the disease. Regular monitoring of these parameters may aid in better management of diabetic patients.
Highlight :
-
Diabetic patients had significantly higher cholesterol, triglyceride, FBS, and HbA1c levels.
-
No notable differences in RBC, WBC, or platelet counts were found between groups.
-
Monitoring biochemical markers is vital for diabetes management.
Keywords : Type 2 Diabetes, Blood Parameters, Cholesterol, Triglycerides, Glycemic Control
References
1. L. J. Lamb and A. P. Day, “New Diagnostic Criteria for Diabetes Mellitus: Are We Any Further Forward?,” Annals of Clinical Biochemistry, vol. 37, pp. 588–592, 2000.
2. M. Shim and T. England, “Diabetes Mellitus,” Specialty Laboratories, updated May 10, 2004 [cited May 6, 2004].
3. B. Biadgo, M. Melku, S. M. Abebe, and M. Abebe, “Hematological Indices and Their Correlation With Fasting Blood Glucose Level and Anthropometric Measurements in Type 2 Diabetes Mellitus Patients in Gondar, Northwest Ethiopia,” Diabetes, Metabolic Syndrome and Obesity, pp. 91–99, 2016.
4. D. Lateef, N. Nasser, and O. Mohsein, “The Relationships Between Aplein, Vaspin and Thyroid Hormone Levels in Obese Diabetic and Non-Diabetic Women,” Journal of Experimental and Clinical Medicine, vol. 41, no. 2, pp. 239–245, 2024.
5. S. Gupta, M. T. Nayak, J. D. Sunitha, G. Dawar, N. Sinha, and N. S. Rallan, “Correlation of Salivary Glucose Level With Blood Glucose Level in Diabetes Mellitus,” Journal of Oral and Maxillofacial Pathology, vol. 21, no. 3, pp. 334–339, 2017.
6. E. Palella et al., “Laboratory Parameters of Hemostasis, Adhesion Molecules, and Inflammation in Type 2 Diabetes Mellitus: Correlation With Glycemic Control,” International Journal of Environmental Research and Public Health, vol. 17, no. 1, p. 300, 2020.
7. M. Inoue, E. Maehata, M. Yano, M. Taniyama, and S. Suzuki, “Correlation Between the Adiponectin-Leptin Ratio and Parameters of Insulin Resistance in Patients With Type 2 Diabetes,” Metabolism, vol. 54, no. 3, pp. 281–286, 2005.
8. N. A. Abdulmuttaleb, M. Q. Mohammed, and O. A. Mohsein, “Exploring the Connection Between Inflammatory Cytokines, Hypertension, and Diabetes in Angina Patients,” Cytokines, vol. 14, no. 15, p. 16, 2024.
9. D. M. Nathan, “The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview,” Diabetes Care, vol. 37, no. 1, pp. 9–16, 2014.
10. A. V. B. H. R. Monitoring, “A View Beyond HbA1c: Role of Continuous Glucose Monitoring,” 2019 [cited Apr. 15, 2020]. Available: [https://doi.org/10.6084/](https://doi.org/10.6084/)
11. M. Rewers et al., “ISPAD Clinical Practice Consensus Guidelines 2014. Assessment and Monitoring of Glycemic Control in Children and Adolescents With Diabetes,” Pediatric Diabetes, 2014.
12. S. Mohammad, A. Mohsen, and I. Jalil, “Assessing the Prevalence of Bacterial Vaginosis Among Infertile Women in Thi-Qar Province, Iraq,” Infection, Epidemiology and Microbiology, vol. 10, no. 4, 2024.
13. A. Rydin et al., “The Humanistic Burden of Type 1 Diabetes Mellitus in Europe: Examining Health Outcomes and the Role of Complications,” PLoS One, Nov. 2016.
14. S. Ballasalla, L. B. Smith, A. Vasquez, H. Rodriguez, and K. Vehik, “Addressing the Burdens of Type 1 Diabetes in Youth,” Clinical Practice, vol. 9, no. 4, pp. 409–424, 2012 [cited Apr. 18, 2020].
15. A. N. Faisal, A. M. Abbas, and O. A. Mohsein, “Histological and Cytokine-Based Biomarkers in the Early Diagnosis of Cancer,” Indonesian Journal of Health Sciences and Medicine, vol. 2, no. 2, pp. 10–21070, 2025.
16. T. Danne et al., “ISPAD Clinical Practice Consensus Guidelines 2018: Insulin Treatment in Children and Adolescents With Diabetes,” Pediatric Diabetes, vol. 19, pp. 115–135, Oct. 2018.
17. M. Inoue, E. Mahatma, M. Yano, M. Taniya, and S. Suzuki, “Correlation Between the Adiponectin-Leptin Ratio and Parameters of Insulin Resistance in Patients With Type 2 Diabetes,” Metabolism, vol. 54, no. 3, pp. 281–286, 2005.
18. H. A. Khan, “Clinical Significance of HbA1c as a Marker of Circulating Lipids in Male and Female Type 2 Diabetic Patients,” Acta Diabetologica, vol. 44, pp. 193–200, 2007.
19. S. H. Alzahrani et al., “Association Between Glycated Hemoglobin (HbA1c) and the Lipid Profile in Patients With Type 2 Diabetes Mellitus at a Tertiary Care Hospital: A Retrospective Study,” Diabetes, Metabolic Syndrome and Obesity, pp. 1639–1644, 2019.
20. N. Hasan et al., “Effect of Electronic Smoking (Vaping) on Thyroid Hormones Level and Lipid Profile in Men,” Ukrainian Biochemical Journal, vol. 96, no. 5, pp. 55–64, 2024.
21. M. Miller et al., “Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association,” Circulation, vol. 123, no. 20, pp. 2292–2333, 2011.
22. B. Bozkurt et al., “Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association,” Circulation, vol. 134, no. 23, pp. e535–e578, 2016.
23. S. V. Arnold et al., “Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association,” Circulation, vol. 141, no. 19, pp. e779–e806, 2020.
24. S. D. De Ferranti et al., “Type 1 Diabetes Mellitus and Cardiovascular Disease: A Scientific Statement From the American Heart Association and American Diabetes Association,” Circulation, vol. 130, no. 13, pp. 1110–1130, 2014.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Mohammed J.I. Al-Shammari
This work is licensed under a Creative Commons Attribution 4.0 International License.
